Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

https://www.youtube.com/watch?v=xuTKPPZrxy4
Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
  • Home
  • 2025
  • August
  • 21
  • Legal Case Highlights Critical Need for Pharmacist Documentation in Vaccine Administration
  • Industries
  • Pharma News

Legal Case Highlights Critical Need for Pharmacist Documentation in Vaccine Administration

Pharm'Up 2 min read

A recent U.S. Court of Appeals ruling has underscored the critical importance of meticulous documentation in pharmacy practice, particularly concerning vaccine administration. The case, detailed by Jim Ruble, PharmD, JD, involved a patient’s lawsuit against a national chain pharmacy that was ultimately dismissed due to insufficient evidence—a consequence of incomplete records.

The lawsuit stemmed from a patient who, in December 2017, received two vaccinations simultaneously: a diphtheria-tetanus-pertussis booster (Tdap) and a pneumococcal polysaccharide vaccine. Both were administered so closely that they appeared to be a single injection site. Immediately after the first shot, the patient experienced significant pain. Over the next two days, the pain and inflammation in her shoulder worsened, leading to a diagnosis of complex regional pain syndrome.

The patient’s legal team filed a lawsuit in December 2020, alleging that the negligent administration of the pneumococcal vaccine was the cause of her “painful and permanent” nerve injuries. However, the case faced a critical hurdle: there was no documentation or witness recollection to establish which of the two vaccines was administered first.

The Legal Conundrum

The lack of this seemingly small detail had major legal implications due to the National Childhood Vaccine Injury Act (VIC). This 1986 federal law created a specific program for compensating individuals for injuries caused by certain vaccines, including the Tdap booster. Claims for these injuries must be made through the VIC program, which grants legal immunity to pharmacists and manufacturers from civil lawsuits. Crucially, the pneumococcal vaccine is not covered by the VIC program.

Therefore, the success of the patient’s lawsuit hinged entirely on proving that her injury was caused by the pneumococcal vaccine, not the Tdap booster. Without a record of the administration sequence, it was impossible to establish a definitive link. The trial court judge ruled that a jury would be forced to guess at the cause, and the U.S. Court of Appeals for the Fourth Circuit upheld this decision. The court acknowledged the difficult position this placed the patient in but affirmed that the absence of a “causative agent” was a fatal flaw in the case.

The outcome of this lawsuit serves as a powerful reminder for pharmacists. As Dr. Ruble notes, a single sentence documenting the order of vaccinations could have provided the crucial evidence needed to proceed with the case, either in civil court or with the VIC program. The case highlights the complex balance within the legal system and the profound responsibility of pharmacists to maintain detailed and accurate records to protect both their patients and themselves.

About the Author

Pharm'Up

Author

An E-platform for Pharma Learners

View All Posts

Post navigation

Previous: Walgreens Ramps Up Staffing, Technology for 2025 Flu Vaccine Season
Next: FDA Clears Signos as First Over-the-Counter Continuous Glucose Monitor for Weight Management

Related Stories

Pharm up 385
2 min read
  • Pharma News

Targeting RNA Modification: FTO Enzyme Emerges as a Biomarker and Therapeutic Target in Gastrointestinal Cancers

Pharm'Up
Pharm up 384
2 min read
  • Pharma News

Advancing Oncology Care: Zydus and Formycon Secure USFDA BLA Acceptance for FYB206, the First Publicly Announced Keytruda Biosimilar

Pharm'Up
Pharm up 383
2 min read
  • Pharma News

Strengthening Regulatory Oversight: India Proposes Strict Advertising Bans on Prescription Drugs for Retailers and Wholesalers

Pharm'Up

Recent Posts

  • Pharmacovigilance Assistant Recruitment: Indian Pharmacopoeia Commission (IPC) Hiring at SVIMS, Tirupati
  • AIIMS Jodhpur Recruitment: Project Research Scientist-I Position in Neurosurgery
  • AYUSH-CCRUM Funded Senior Research Fellow (SRF) Position at INST Mohali
  • Research Fellowships at AIIMS Jodhpur: Openings for Research Associate-III
  • Lupin Limited Walk-In Interview: Production Apprentice Openings for Freshers

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharm up 405
2 min read
  • Pharma Jobs

Pharmacovigilance Assistant Recruitment: Indian Pharmacopoeia Commission (IPC) Hiring at SVIMS, Tirupati

Pharm'Up
Pharm up 403
2 min read
  • Pharma Jobs

AIIMS Jodhpur Recruitment: Project Research Scientist-I Position in Neurosurgery

Pharm'Up
Pharm up 402
1 min read
  • Pharma Jobs

AYUSH-CCRUM Funded Senior Research Fellow (SRF) Position at INST Mohali

Pharm'Up
Pharm up 401
2 min read
  • Pharma Jobs

Research Fellowships at AIIMS Jodhpur: Openings for Research Associate-III

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.